Dec 15 (Reuters) - Adaptive Biotechnologies said on Monday it has signed two non-exclusive deals with Pfizer to support ...

Through a joint study with Professor Yoo Seung-ah of the Medical Life Science Class at Catholic University of Korea, the ...

Once seen as an age-related condition, arthritis is now affecting young Indians. Experts explain the lifestyle, obesity, and ...

Dec 15 () - Adaptive Biotechnologies ​said on ‌Monday it has ‌signed two non-exclusive deals with Pfizer ⁠to ‌support ...

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritisA data licensing agreement to access ...

SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...

Here’s what to know about how common bottom-of-foot pain is, why it happens and the most reliable ways to find relief.

A federal district court denied the Board of Trustees of the University of Arkansas’s motion to dismiss retaliation, discrimination, and hostile work environment claims under the Americans with ...

Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...

Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating.

A new study has linked air pollution exposure and immune-system changes that often precede the onset of autoimmune diseases.

Investing.com -- Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock rose 4.3% in Monday premarket trading following the announcement of two non-exclusive agreements with Pfizer Inc (NYSE:PFE) that ...